Login / Signup

A comparison of postoperative complications following cardiac implantable electronic device procedures in patients treated with antithrombotic drugs.

Muhammed DemirMehmet OzbekNihat PolatAdem AktanBünyamin YıldırımLokman ArgunKamran İldırımlıLezgin DursunCansu ÖztürkTuncay GüzelRaif KılıçNizamettin Toprak
Published in: Pacing and clinical electrophysiology : PACE (2022)
The incidence and severity of complications may be lower in patients treated with periprocedurally antiplatelet or NOAC therapy when compared with warfarin therapy. Further randomized control studies are required to confirm our findings.
Keyphrases
  • atrial fibrillation
  • risk factors
  • double blind
  • open label
  • venous thromboembolism
  • left ventricular
  • stem cells
  • clinical trial
  • placebo controlled
  • phase iii
  • phase ii
  • bone marrow
  • direct oral anticoagulants